We do not expect to make any significant repurchases in 2009. Glaxosmithkline capital plc annual report 2008 gsk. It has 110 000 employees all over the world and sales of. Pages 1 to 147 constitute the unilever annual report and accounts. These pages provide information and data taken from the glaxosmithkline plc gsk annual report 20. Annual reports investor relations chugai pharmaceutical. Gsk annual report 2016 free ebook download as pdf file.
Your employees and customers covet new technologies, like digital, mobile, and social. Free cash flow and underlying operating margin are nongaap measures. Since 2008, we have had 16 new drugs and vaccines approved in the usa. Glaxosmithkline capital plc directors report for the year ended 31st december 2008 the directors submit their report and the audited financial statements for the year ended 31st december 2008. Annual reports archive annual report our annual report 2019 provides a comprehensive overview of novartis, including our corporate governance, compensation practices, and. Annual report 2008 grow deliver simplify do more, feel better, live longer.
To request a printed copy of our report free of charge, please contact. In the uk, gsk s annual report order line operated by the companys registrars, equiniti limited. The investor relations website contains information about amgen inc. The information in this document is only a summary of certain information contained in our annual report for the year ended 31 december 2008 and does not contain all the information needed to give as full an understanding of the results, state. This is a pdf version of the unilever annual report and accounts 2019 and is an exact copy of. Gsk annual report 2016 glaxo smith kline financial statement. The first fixed dose combination medicine for benign prostatic hyperplasia. Annual reports with our annual report, you will come abreast with overview insight of our companys performance and prospects our annual report will provide you with insight on our performance and prospects, the board of directors and the management team, corporate governance, financial data, information on market conditions, corporate responsibility, shareholders information, and marketing. If there are transactions that come to our attention that require adjustments and sufficient information is available, those adjustments may be applied directly through revision to this report or may be made in subsequent reporting periods. Glaxosmithkline gsk announced today that the swiss regulatory authority, swissmedic, has granted approval for duodart, a fixed dose combination fdc of dutasteride 0. We have a longstanding relationship with the governmentfunded science institution, oswaldo cruz foundation, to manufacture vaccines for public health priorities in brazil.
Food and drug administration fda has approved a supplemental biologic license application sbla for the use of arzerra ofatumumab, a cd20directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia cll. They do not constitute the official version of the gsk annual report 20 taken as a whole and do not contain sufficient information to allow a full understanding of the results and the state of affairs of gsk. Principal activities the company provides financial services to fellow subsidiaries of the glaxosmithkline group of companies the group. A description of these risks and uncertainties can be found in pfizers most recent annual report on form 10k and in its subsequent reports on form 10q, including in the sections thereof captioned risk factors and forwardlooking information and factors that may affect future results, as well as in its subsequent reports on form. Annual report 2008 a undertake a swot analysis of the company. We make a wide range of prescription medicines, prescribed vaccines and consumer healthcare products. Our strategy is delivering and we believe that gsk is now moving to a position where it can deliver longterm financial performance on a sustainable basis for shareholders. We research, manufacture and make available a broad range of medicines and vaccines that benefit people.
The full, comprehensive operational and financial report for the year ended dec 31, 2014. At gsk we perform in unison by following our strong value system and ethical guidelines as a source of direction and inspiration to help achieve our vision. Gsk annual report 2011 pdf 5 mb annual report 2010 30 march 2011. Thursday 17 march 2016, london, uk lse announcement glaxosmithkline plc publication of 2015 annual report glaxosmithkline plc the company will today publish on the companys website. The calculation of free cash flow is described on page 58 and a reconciliation is. Each and every member of the gsk family plays a vital role in improving the quality of human life. Gsk consumer nigeria plc operates a fair, orderly, transparent investors and shareholders relations from within and around the globe. Your directors are pleased to present the annual report on the business and operations of your company and the audited accounts of the company for the year ended 31st december, 2007. Notwithstanding the references we make in this annual report to glaxosmithklines website. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare. Internal controls and risk management systems risk management is an important factor in the longterm success of the group. In 2009, gsk acquired stiefel laboratories, then the worlds largest independent. We are a scienceled global healthcare company with a special purpose. Directors report the directors have pleasure in submitting their report for the year ended 31st december 2009 1.
Glaxosmithkline plc gsk is a british multinational pharmaceutical company headquartered in brentford, london. Accounts and reports regulations 2008 as amended by the companies. Glaxosmithkline plc gsk is a british multinational pharmaceutical company headquartered in. By 2020 total waste sent for disposal will be at or below 2008 levels despite. Questions about this report should be submitted to the gsk response center at 18887250016.
Gen announced today that the phase iii study orcharrd of ofatumumab arzerra plus chemotherapy versus rituximab plus chemotherapy to treat relapsed or refractory diffuse large bcell lymphoma dlbcl did not meet its primary endpoint as there was no statistically significant difference in progression free survival pfs between the. Click the button below to request a report when hardcopies become available. Interactive html glaxosmithkline plc does not currently have any hardcopy reports on. Gsk pakistanannual report 2007 free download as pdf file.
Glaxosmithkline consumer healthcare limited directors report your directors are pleased to present the annual report on the business and operations of your company and the audited accounts of the company for the year ended 31 december 2010. So isaiah forbes concluded his annual report as president of the st. Tesco plc has reached its limit for free report views. Gsk annual report 2017 pdf 17 mb annual report 2016. Medicboys big adventure a fun guide to advances in personalized healthcare 7. In addition to the financial risk management disclosed in the treasury policy note on page 8 note 2, at a company level, the principal risks and uncertainties. Glaxosmithkline announces swiss approval of duodart gsk. The annual report is prepared in accordance with the danish financial statements act. Worlds second largest pharmaceutical company, after pfizer, is glaxosmithkline gsk, which was emerged from two big companies glaxowellcome and smithklinebeecham in 2000. Gsk pakistanannual report 2007 glaxo smith kline dividend.
Free cash flow in 2011 was impacted by the loss of sales of pandemic. Pdf tesco plc does not currently have any hardcopy reports on. The pressures institutions like yours face are constantly evolvingand getting ahead of them is a real challenge. Glaxosmithkline plc does not currently have any hardcopy reports on. Ordered to be printed by the house of commons 16 july 2008. We issue an annual report in februarymarch each year. Annual report 2014 page 3 managements statement board and board of directors have today considered and adopted the annual report the executive of glaxosmithkline pharma as for the financial year 1 january 31 december 2014.528 1481 382 1474 1067 1555 901 745 806 552 1217 1557 374 46 466 895 360 1124 914 140 1470 712 959 1375 625 1459 1302 402 347 997 1194 381 1237 809 474 1046 136 490 809 7 1495 196